MUC5B and lung adenocarcinoma: We extended progression-free survival (PFS) analysis using TCGA survival data, revealing significant association between MUC5B and PFS in lung adenocarcinoma (p<0.05), reinforcing its lymph node metastasis relevance (Supplementary Figure 2).